-
What's new
- All What's new
-
European
- What's new - All
- <hr>
- What's new - last 24 hrs
- What's new - last 7 days
- What's new - last 30 days
- <hr>
- New EU Legislation
- European Commission
- European Banking Authority
- European Securities and Markets Authority
- European Insurance and Occupational Pensions Authority
- <hr>
- Consultations and similar
- Commentaries
- <hr>
- Downloads and Exports
- Latest news by Topics
-
International
- What's new - All
- <hr>
- What's new - last 24 hrs
- What's new - last 7 days
- What's new - last 30 days
- <hr>
- Bank for International Settlements
- Basel Committee on Banking Supervision
- Egmont Group
- International Association of Insurance Supervisors
- International Monetary Fund
- <hr>
- Consultations and similar
- Commentaries
- <hr>
- Downloads and Exports
- Latest news by Topics
- Downloads and Exports
- Legislation
- Organisations
-
Commentaries
- Consultations
- Sanctioned regimes
- IFRSs
- Regulatory calendar
- Quicklinks
-
More
Table of Contents
Page Overview
Document Overview
AI Summary of Article 269a Treatment of non-performing exposures (NPE) securitisations
This Article provides the framework for Non-Performing Exposure (NPE) securitisation, defining terms integral to the regulatory process. A qualifying traditional NPE securitisation must demonstrate a non-refundable purchase price discount of at least 50% from the outstanding amount at the point of transfer to a Special Purpose Entity (SSPE).
Risk weights for securitisation positions are primarily set at a minimum of 100%, with specific provisions for senior positions in qualifying traditional NPE securitisations. Institutions employing the Internal Ratings-Based (IRB) Approach must exclude certain methodologies when calculating risk-weighted exposures and must accurately assess non-refundable purchase price discounts, factoring in realised losses throughout the transaction's lifespan.
AI Disclaimer
Please note that AI-generated content should not be considered legal advice. Users are encouraged to consult with qualified professionals or legal advisors where specific legal guidance is required.
We are committed to transparency and responsible use of AI in a way that supports, but never replaces, human expertise.
If you have any questions or concerns about the use of AI on our platform, please feel free to contact us.
Article 269a Treatment of non-performing exposures (NPE) securitisations
1. For the purposes of this Article:
(a) "NPE securitisation" means an NPE securitisation as defined in point (25) of Article 2 of Regulation (EU) 2017/2402;
(b) "qualifying traditional NPE securitisation" means a traditional NPE securitisation where the non-refundable purchase price discount is at least 50 % of the outstanding amount of the underlying exposures at the time they were transferred to the SSPE.
2. The risk weight for a position in an NPE securitisation shall be calculated in accordance with Article 254 or 267. The risk weight shall be subject to a floor of 100 %, except when Article 263 is applied.
3. By way of derogation from paragraph 2 of this Article, institutions shall assign a risk weight of 100 % to the senior securitisation position in a qualifying traditional NPE securitisation, except when Article 263 is applied.